TY - JOUR
T1 - Prevention of sudden cardiac death
T2 - Return to sport considerations in athletes with identified cardiovascular abnormalities
AU - Link, Mark S.
PY - 2009/9
Y1 - 2009/9
N2 - Sudden cardiac death in the athlete is uncommon but extremely visible. In athletes under age 30, genetic heart disease, including hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and ion channel disorders account for the majority of the deaths. Commotio cordis, involving blunt trauma to the chest leading to ventricular fibrillation, is also a leading cause of sudden cardiac death in young athletes. As the athlete ages, coronary atherosclerosis contributes to an increasing incidence of sudden death during sporting activities. For athletes with aborted sudden death or arrhythmiarelated syncope, an implantable cardioverter defibrillator is generally indicated, and they should be restricted from most competitive sports. Participation in competitive athletics for athletes with heart disease should generally follow the recently published 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities.
AB - Sudden cardiac death in the athlete is uncommon but extremely visible. In athletes under age 30, genetic heart disease, including hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, and ion channel disorders account for the majority of the deaths. Commotio cordis, involving blunt trauma to the chest leading to ventricular fibrillation, is also a leading cause of sudden cardiac death in young athletes. As the athlete ages, coronary atherosclerosis contributes to an increasing incidence of sudden death during sporting activities. For athletes with aborted sudden death or arrhythmiarelated syncope, an implantable cardioverter defibrillator is generally indicated, and they should be restricted from most competitive sports. Participation in competitive athletics for athletes with heart disease should generally follow the recently published 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities.
UR - http://www.scopus.com/inward/record.url?scp=69949141946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=69949141946&partnerID=8YFLogxK
U2 - 10.1136/bjsm.2008.054882
DO - 10.1136/bjsm.2008.054882
M3 - Review article
C2 - 19734503
AN - SCOPUS:69949141946
SN - 0306-3674
VL - 43
SP - 685
EP - 689
JO - British Journal of Sports Medicine
JF - British Journal of Sports Medicine
IS - 9
ER -